Ex Vivo News and Research

RSS

Gas embolotherapy holds great potential for treating cancer

Embolization -- the use of various techniques to cut off the blood vessels that feed tissue growth -- has gained traction over the past few decades to treat cancerous tumors.

6 Jun 2018

Investigational technology could increase donor organ supply for lung transplants

As many as 80 percent of lungs from organ donors are not used, either because they are not in good enough condition to transplant, or there are doubts about their quality and there is no way to verify their condition.

23 May 2018

Using Cord Blood to Alleviate the Symptoms of Autism

Cord blood has been studied extensively for the treatment of hematological diseases such as cancer and sickle cell anemia, but is now in phase II trials for the alleviation of autism. Dr. Ann Smith, director of Smart Cells who provided the cord blood for the trial, discusses the research and it's potential.

9 Apr 2018

New ocular inserts allow patient's cornea to absorb more antibiotics

The anatomic and physiologic structure of the eyes constitutes by itself an important barrier when administering medicine. The amount of medicine that passes through the cornea by applying creams or drops is very limited and it is necessary to develop alternative, more effective ways of administering them ocularly.

22 Mar 2018

Novel oncolytic virus expressing BiTE molecule elicits T cell-mediated killing of tumor cells

In a research article published in EMBO Molecular Medicine, a group of scientists at the University of Oxford have described a new twist on cancer immunotherapy, combining two independent cell killing approaches in a single therapeutic with high potency and broad applicability.

13 Mar 2018

NETRF awards six new research grants to improve treatments for neuroendocrine tumors

The Neuroendocrine Tumor Research Foundation today awarded six new research grants totaling $1.85 million to leading academic institutions around the world.

5 Mar 2018

Scientists explore factors that most affect our immune system

Why do we respond differently to infections or vaccines? Why are some people allergic to pollen? These are still unanswered questions in biological and medical science.

28 Feb 2018

Clinical trial studying type 1 diabetes reaches full enrollment

A clinical trial studying type 1 diabetes has reached full enrollment. The Sanford Project: T-Rex Study, a Phase 2 clinical trial conducted collaboratively by Sanford Health and Caladrius Biosciences, Inc., has completed enrollment of 110 children with type 1 diabetes. The study started with two sites at Sanford Health in Sioux Falls, South Dakota, and Fargo, North Dakota, and expanded to 13 additional sites across the United States.

19 Feb 2018

Cell membrane nanofragments can act as nucleation sites for mineralization during bone formation

The burst of cells forming cartilage is associated with mineralization during the early stages of bone formation, and nanofragments of the cell membranes can act as nucleation sites for amorphous calcium phosphate, as reported in two studies just published in Integrative Biology and ASC Biomaterials Science and Engineering.

14 Feb 2018

MILabs completes installation of latest VECTor5CT system at University of Copenhagen

MILabs announced today that it has successfully completed the installation of its top-of-the-line multimodality PET-SPECT-UHR CT in the laboratory of Prof. Maiken Nedergaard, M.D, D.M.Sci. – Center for Translational Neuroscience, Division of Glial Disease and Therapeutics.

6 Feb 2018

VUMC reaches new record in performing heart transplants

Vanderbilt University Medical Center performed a record number of heart transplants in 2017, surpassing the 2016 milestone and securing its place as the second-busiest heart transplant program in the country.

5 Feb 2018

NYU Langone Health introduces new lung transplant program

The Transplant Institute at NYU Langone Health has launched a new lung transplant program, the third program of its kind in the greater New York City area, expanding regional access to this specialized level of care.

30 Jan 2018

Research could pave way for more effective allergy medicine

Researchers have found a new mechanism in which an antibody can prevent allergic reactions in a broad range of patients. It is a scientific breakthrough, which could pave the way for a far more effective allergy medicine.

25 Jan 2018

New blood stabilization method prolongs lifespan of blood samples for CTC profiling

A new blood stabilization method, developed at the Massachusetts General Hospital Center for Engineering in Medicine, significantly prolongs the lifespan of blood samples for microfluidic sorting and transcriptome profiling of rare circulating tumor cells (CTCs), living cancer cells carried in the bloodstream.

9 Jan 2018

Researchers use genomics to advance understanding of Parkinson´s disease

It is widely known that genomics has already begun to influence medicine and that bioinformatics holds the key for developing new medical approaches, but how does medical genomics really work?

19 Dec 2017

MUSC researchers develop ex vivo model of pressure-induced cellular injury in the brain

Hundreds of thousands of patients from newborns to the elderly are forced to grapple with the devastation of brain injury each year, and unlike many diseases where certain demographics are protected, brain injury can happen to anyone, anytime and anywhere.

4 Dec 2017

Orchard Therapeutics opens new facility for technical operations in San Francisco Bay area

Orchard Therapeutics, a clinical-stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the opening of a second facility for technical operations in the San Francisco Bay Area.

1 Dec 2017

Noninvasive brain imaging reveals surgical skills acquisition and expertise of trainees

While simulation platforms have been used to train surgeons before they enter an actual operating room (OR), few studies have evaluated how well trainees transfer those skills from the simulator to the OR.

17 Nov 2017

Aspect Imaging announces receipt of CE marking for neonatal-dedicated MRI system

Aspect Imaging, a developer of compact high-performance MRI systems, announces today that it has received CE marking for the neonatal-dedicated MRI system, Embrace Neonatal MRI System, which enables preparation and scanning of newborns, without having to transport them from the NICU. Embrace® Neonatal MRI can now be used and sold in EU countries and in non-EU countries that rely on CE certification.

9 Nov 2017

Novel approach could help predict how well patients respond to cancer treatment

A novel approach developed by researchers from the University of Leicester and the MRC Toxicology Unit could help to predict how well patients respond to drugs designed to fight various forms of cancer.

8 Nov 2017